Subscribe to
this category


A total of 126 posts are filed under Business
Arcturus Therapeutics Announces Collaboration with Takeda Pharmaceuticals to Develop RNA–based Therapeutics for the Treatment of Nonalcoholic Steatohepatitis (NASH)
San Diego, Calif., Dec 6, 2016 – Arcturus Therapeutics, Inc. (“Arcturus” or the “Company”), a leading RNA medicines company,… Continue Reading
Ultragenyx Gives Arcturus Rocket Shot in Potential $1.57B Deal
By Marie Powers, News Editor (Source) The up front is only $10 million, but Arcturus Therapeutics Inc. stands to collect up to $1.56 billion… Continue Reading
Invitae Announces Major Expansion of Its Pediatric, Neurological and Rare Disease Genetic Test Offerings
 Invitae Corporation (NYSE:  NVTA), a genetic information company, today announced the availability of 24 new and 19 expanded genetic… Continue Reading
Arcturus Therapeutics Announces Strategic Collaboration with Johnson & Johnson Innovation to Discover and Develop RNA Medicines for Defined Indications
San Diego, Calif., June 11, 2015 – Arcturus Therapeutics, Inc., a leading RNA medicines company, announced today that it has entered… Continue Reading
New Hope for Complex Regional Pain Syndrome Patients With New FDA Approval
Grünenthal receives Breakthrough Therapy Designation from U.S. FDA for neridronic acid for the treatment of complex regional pain syndrome… Continue Reading
Alexion, UConn Partner to Fight Rare Diseases
New Haven-based bio-pharmaceutical company Alexion Pharmaceuticals is working with the University of Connecticut to create a fund to support… Continue Reading
New Possibilities for Epidermolysis Bullosa Patients Comes with $21 Million Loan to Amryt Pharma
Amryt Pharma has secured a €20 million ($21 million) loan from the European Investment Bank (EIB) to fund a pivotal trial of its lead… Continue Reading

Follow us on Twitter